Jay Bhattacharya on Public Health
October 12, 2021
An update on the National Nature Assessment
April 23, 2025
Our guest is Dr. Stanley Goldfarb, author of the recently-released Take Two Aspirins and Call Me By My Pronouns, a...
Read moreInflation in the US is at forty-year highs, while interest rates on ten-year Treasury notes just hit 3 percent—signaling trouble...
Read moreOn Monday the White House again was forced to "calm fears" that the United States is engaging in nuclear brinkmanship....
Read moreWhy did Europe advance economically in the postmedieval period? Bas Spliet looks to the writings of Ralph Raico and Hans-Hermann...
Read morePoliticians have become accustomed to conjuring whatever they want through the “miracle” of printing money. But in the real world,...
Read more"Inflation" is back in the headlines, and a lot of nonsense is being said about it. Without much thought whether...
Read moreMarkets are marvelous. They’re the poetry of economics. They are one of the most remarkable technologies humans have ever built....
Read moreJohnny Vedmore is an independent journalist from Cardiff, Wales. He discusses his masterful article on Klaus Schwab's mentors, including Henry...
Read morePoliticians love their buzzwords and talking points, and the Joe Biden White House and the Democratic Party use them as...
Read moreWashington regards the entire world as its "sphere of influence." But now Beijing is looking to follow the US playbook...
Read moreDisclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 ElonsVision. All Rights Reserved.